Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: France Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20053
20062
20073
20082
20105
20111
20121
20132
20142
20153
20165
20178
20187
20194
20203
20214
20223
20231
20241
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated13
Recruiting8
Active, not recruiting8
Unknown status6
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC7
AbbVie5
Acute Leukemia French Association4
Stichting Hemato-Oncologie voor Volwassenen Nederland4
Astellas Pharma Global Development, Inc.3
Astex Pharmaceuticals, Inc.3
Daiichi Sankyo3
Assistance Publique - Hôpitaux de Paris2
Celgene2
French Innovative Leukemia Organisation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute76
Leukemia15
Myelodysplastic Syndromes12
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia, Lymphocytic, Chronic, B-Cell5
Hematologic Neoplasms4
Leukemia, Erythroblastic, Acute4
Leukemia, Megakaryoblastic, Acute4
Leukemia, Monocytic, Acute4
Leukemia, Myelomonocytic, Acute4

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.